Volume | 1,870 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Johnson and Johnson | JNJ | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
148.53 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
103 | 1,870 | - | 143.13 - 175.97 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
07:51:44 | 5 | $ 148.92 | USD |
Johnson and Johnson (JNJ) Options Flow Summary
Johnson and Johnson Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
357.77B | 2.41B | - | 85.16B | 35.15B | 14.59 | 10.18 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Johnson and Johnson News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JNJ Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 144.98 | 150.49 | 143.13 | 148.18 | 9,918,971 | 3.82 | 2.63% |
1 Month | 158.11 | 159.14 | 143.13 | 149.81 | 7,948,376 | -9.31 | -5.89% |
3 Months | 158.07 | 163.11 | 143.13 | 155.40 | 7,645,338 | -9.27 | -5.86% |
6 Months | 151.24 | 163.58 | 143.13 | 155.22 | 7,203,059 | -2.44 | -1.61% |
1 Year | 164.31 | 175.97 | 143.13 | 162.69 | 11,009,420 | -15.51 | -9.44% |
3 Years | 165.21 | 186.69 | 143.13 | 166.00 | 8,440,856 | -16.41 | -9.93% |
5 Years | 138.52 | 186.69 | 109.16 | 157.52 | 8,158,674 | 10.28 | 7.42% |
Johnson and Johnson Description
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total sales are generated in the United States. |